Title: CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE
1 CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING
ANTIBIOTIC RESISTANCE
- Dr. Jolanta Miciuleviciene
- Vilnius City Clinical Hospital
- National Public Health Surveillance Laboratory
BARN 3rd Workshop "Prevention of Surgical Site
Infections" Visby, 2012
2 Discovery of Penicillin Changes
the History of Medicine
- In 1928 Sir Alexander Fleming, a Scottish
bacteriologist, left a Petri dish with
staphylococci uncovered. When he returned, he
noticed that there was mold growing on it. Upon
further examination, he saw that the area around
the mold had no bacteria growing. - Fleming concluded that the mold was releasing a
substance that was inhibiting bacterial growth.
He grew a pure culture of the mold and discovered
that it was a Penicillium, now known to be
Penicillium notatum. -
3(No Transcript)
4Antimicrobial resistance
- Soon after the introduction of the penicillin
into clinical practice, the fact that the
development of antibiotic resistance would be a
problem became apparent. - Resistance to penicillin in some strains of
Staphylococcus was recognized almost immediately
after introduction of the drugs. Resistance to
penicillin today occurs in as many as 90 of all
strains of Staphylococcus aureus
5Antimicrobial resistance
- Most commonly, this refers to infectious microbes
that have acquired the ability to survive
exposures to clinically relevant concentrations
of antimicrobial drugs that would kill otherwise
sensitive organisms of the same strain. -
6Resistant Nosocomial Pathogens
- S.aureus (MRSA, GISA),
- Enterococcus spp. (VRE),
- E.coli (ESBL),
- Klebsiella pneumoniae (ESBL, KPC),
- Enterobacteriaceae (MDR),
- Pseudomonas aeruginosa (MDR),
- Acinobacter baumannii (MDR).
-
-
7European Antimicrobial
Resistance Surveillance Network (EARS Net)
Streptococcus pneumoniae, Staphylococcus
aureus, Enterococcus faecalis, Enterococcus
faecium Escherichia coli, Klebsiella
pneumoniae, Pseudomonas aeruginosa.
8 EARS Net participants in
Lithuania 10 laboratories of microbiology
37 hospitals
9 Number of blood-stream
infections, Lithuania, 2007 2011
10Staphylococcus aureus trends
of invasive isolates resistant to meticillin
(MRSA),Lithuania, 2007-2011
2007m. - 241/22, 2008m. - 280/31, 2009m. -
255/29, 2010m. 257/36, 2011m. 263/16
11Staphylococcus aureus
proportion () of invasive isolates resistant to
methicillin (MRSA), 2010
12 Klebsiella pneumoniae trends
of invasive isolates resistance to
third-generation cephalosporins, fluoroquinolones
and aminoglycosides, Lithuania, 2007-2011
13Klebsiella pneumoniae
proportion () of invasive isolates with
resistance to third-generation cephalosporins,
2010
14Klebsiella pneumoniae
proportion () of invasive isolates with
resistance to carbapenems, 2010
15 Number of K.pneumoniae blood
stream infections, Lithuania, 2007-2011.
16Risk factors of developing bacterial resistance
- Inappropriate prescribing (overprescribing)
- Inappropriate selection of antimicrobial (broad
spectrum cephalosporins, fluoroquinolones,
carbapenems, glycopeptides) - Prolonged administration of antimicrobial.
17Evidence Based
- Evidence-based medicine is the process of
systematically finding, appraising, and using
research findings as the basis for clinical
decisions. - BMJ 19953101122-1126 (29 April)
- William Rosenberg, Anna Donald
- Evidence-based Medicine An Approach to Clinical
Problem-solving
18Evidence-based medicine
- Reference
- Cook PP, Catrou P, Gooch M, Holbert D. Effect
of reduction in ciprofloxacin use on prevalence
of methicillin-resistant Staphylococcus aureus
rates within individual units of a tertiary care
hospital. Journal of Hospital Infection. 2006
64 348-351 - Setting
- 731-bed tertiary care teaching hospital,
Greenville, NC, USA.
19Evidence based medicine
- Intervention
- Reduction - Active monitoring of oral and IV
ciprofloxacin use. - Impact
- Ciprofloxacin use decreased by 31.2
(plt0.0001). MRSA rates decreased from 59.6 to
54.2 (p0.112). Correlation between
ciprofloxacin use and MRSA rates (r0.70 95 CI
-0.01-0.94 p0.053).
20Evidence based medicine
- Reference
- Rahal JJ, Urban C, Horn D, Freeman K,
Segal-Maurer S, Maurer J, Mariano N, Marks S,
Burns JM, Dominick D, Lim M. Class restriction of
cephalosporin use to control total cephalosporin
resistance in nosocomial Klebsiella. JAMA,
1998280(14) 1233-1237 - Setting
- 500-bed university affiliated community
hospital, Queens, NY, USA
21Evidence based medicine
- Intervention
- Restriction - Hospital adopted antibiotic
guidelines restricting routine cephalosporin use.
- Impact
- 80.1 reduction in hospital-wide
cephalosporin use in 1996 compared to 1995. 44
reduction in incidence of ceftazidime-resistant
Klebsiella infection and colonization throughout
medical center (plt0.01) and 70.9 reduction in
all intensive care units (plt0.001).
22Evidence based medicine
- Intervention
- Restriction - Hospital adopted antibiotic
guidelines restricting routine cephalosporin use.
- Impact
- 80.1 reduction in hospital-wide
cephalosporin use in 1996 compared to 1995. 44
reduction in incidence of ceftazidime-resistant
Klebsiella infection and colonization throughout
medical center (plt0.01) and 70.9 reduction in
all intensive care units (plt0.001).
23Take home message
- Inappropriate selection and prolonged
administration of antimicrobials
Fluoroquinolones Cephalosporins Carbapenems Glycopeptides. S.aureus (MRSA, GISA), Enterococcus spp. (VRE), E.coli (ESBL), Klebsiella pneumoniae (ESBL, KPC), Enterobacteriaceae (MDR), Pseudomonas aeruginosa (MDR), Acinobacter baumannii (MDR).
THANK YOU !